InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,090.02
(
-0.15%
)
Post# of 13959
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Letterpenny

Send PM Follow Ignore
Followers 7
Posts 6049
Boards Moderated 0
Alias Born 06/27/2018

Letterpenny

Member Level

Re: None

Friday, 06/28/2019 7:52:37 AM

Friday, June 28, 2019 7:52:37 AM

Post# of 13959
PharmaTimes

We talk to Eric Hughes about his role as Novartis’ global development unit head of Immunology, Hepatology and Dermatology

What is your background and current role?

I joined Novartis in 2015 as the head of the development unit for immunology, hepatology and dermatology. It’s our job to oversee the clinical development and regulatory approvals of a number of innovative treatments, both in development and already in market. I’ve also just recently been appointed head of drug development for the company in China.

Before joining Novartis, I worked for other pharmaceutical companies on projects ranging from Phase I to Phase III development. I’m a licensed physician with specialty training in infectious diseases – with a doctoral degree in immunology from Yale.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up